簡介:LY2940680是一種 smoothened 受體拮抗劑。
LY2940680物理化學性質(zhì):
密度 |
1.4±0.1 g/cm3 |
沸點 |
703.5±60.0 °C at 760 mmHg |
分子式 |
C26H24F4N6O |
分子量 |
512.502 |
閃點 |
379.3±32.9 °C |
精確質(zhì)量 |
512.1948 |
PSA |
67.15 |
LogP |
2.7 |
蒸汽壓 |
0.0±2.2 mmHg at 25°C |
折射率 |
1.634 |
LY2940680詳細介紹:
中文名稱: |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 |
中文別名: |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺;4-氟-N-甲基-N-(1-(4-(1-甲基-1H-吡唑-5-基)二氮雜萘-1-基)哌啶-4-基)-2-(三氟甲基)苯甲酰胺;Taladegib (LY2940680) 抑制劑 |
英文名稱: |
LY2940680 |
英文別名: |
LY2940680;4-Fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide;4-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide;Taladegib (LY2940680);LY-2940680;Taladegib;4-Fluoro-N-methyl-N-[1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)benzamide |
CAS號: |
1258861-20-9 |
分子式: |
C26H24N6OF4 |
詳細描述 |
博飛美科提供1258861-20-9,LY2940680,Medlife,上?,F(xiàn)貨。 Medlife,致力于提供高品質(zhì)、高性價比小分子化合物的產(chǎn)品。 Medlife小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 Hedgehog / SMO拮抗劑,抑制Hh信號,Taladegib (LY2940680) 是一種 smoothened 受體拮抗劑。 查詢關(guān)鍵詞:“1258861-20-9,LY2940680,PC15840,Medlife,上?,F(xiàn)貨”。 |
LY2940680參考文獻:
[1]. Fraveto A, et al, Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS One. 2015 Nov 16;10(11):e0142124.
[2]. Hoch L, et al. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. FASEB J. 2015 May;29(5):1817-29.
[3]. Ma W, et al. Reduced Smoothened level rescued Aβ-induced memory deficits and neuronal inflammation in animal models of Alzheimer's disease. J Genet Genomics. 2018 May 20;45(5):237-246.
產(chǎn)品技術(shù)規(guī)格說明書由上海創(chuàng)賽科技有限公司收集整理,僅作參考使用。